Health The Sciences The Worrying Ways in Which Biocon’s Itolizumab Trial Was Deeply Flawed Priyanka Pulla 24/08/2020 0 Several discrepancies and assumptions point to a badly done...Read More
Government Health The Sciences Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque? Anupam Kumar Singh and Dinesh Thakur 31/07/2020 0 It's not clear how the Drug Controller General of...Read More
